892553-42-3

892553-42-3 structure

892553-42-3 structure

Name: Etaracizumab
Chemical Name: Etaracizumab
CAS Number: 892553-42-3
Molecular Formula:
Molecular Weight:
Catalog: Signaling Pathways Cytoskeleton Integrin
Create Date: 2018-12-03 10:08:50
Modify Date: 2024-04-02 16:54:06
Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer[1].

Name	Etaracizumab

Description	Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cytoskeleton >> Integrin
References	[1]. Hersey P, et al. A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma. Cancer. 2010 Mar 15;116(6):1526-34.

No Any Chemical & Physical Properties